PA
AVAH icon

PharVision Advisers’s Aveanna Healthcare AVAH Stock Holding History

PharVision Advisers’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
14,135
-5,957
-30% -$42K 2.28% 7
2026
Q1 		$129K Sell
20,092
-21,059
-51% -$163K 1.31% 23
2025
Q4 		$336K Buy
41,151
+20,556
+100% +$186K 0.17% 221
2025
Q3 		$183K Buy
20,595
+5,630
+38% +$35.6K 0.1% 534
2025
Q2 		$78.3K Buy
+14,965
New +$76.1K 0.11% 262

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's AVAH Position: Q2 2026 in Review

PharVision Advisers reduced its Aveanna Healthcare (AVAH) stake by 30% in Q2 2026, selling an estimated $42K and leaving 14,135 shares worth $121K. The position accounts for 2.28% of the portfolio, ranked #7.

PharVision Advisers first reported a position in AVAH in Q2 2025 and has held it in 5 quarters since. The position peaked at $336K in Q4 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • PharVision Advisers held 14,135 shares of Aveanna Healthcare worth $121K as of Q2 2026.
  • PharVision Advisers sold 5,957 Aveanna Healthcare shares in Q2 2026, an estimated $42K.
  • Aveanna Healthcare made up 2.28% of PharVision Advisers's portfolio in Q2 2026, its #7 holding.
  • PharVision Advisers first reported a position in Aveanna Healthcare in Q2 2025 and has held it in 5 quarters since.
  • PharVision Advisers's Aveanna Healthcare position peaked at $336K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.